As 2019 was about to close, the world faced a health emergency that would soon become a global pandemic. No economy or country was prepared for the unprecedented changes that the Coronavirus would bring. It’s now the latter half of the year, and the pandemic is still very much present. Many countries are still facing…
CHICAGO–(BUSINESS WIRE)–NuMed, a rapidly expanding Chicago-based vertically integrated Cannabis company, has launched their new name and brand NuEra. NuEra covers their three current Illinois retail locations, a newly acquired cultivation center in Rochelle IL, and their new brand of Flower and Prerolls. The name NuEra highlights the fact that legalization in Illinois didn’t just change…
LONDON–(BUSINESS WIRE)–The global functional chewing gum market size is expected to grow by USD 1.83 billion as per Technavio. This marks a significant market growth compared to the 2019 growth estimates due to the impact of the COVID-19 pandemic in the first half of 2020. Steady growth is expected to continue throughout the forecast period,…
LOS ANGELES–(BUSINESS WIRE)–XS Financial Inc., (“XS Financial”, “XS” or the “Company”) (CSE: XSF) (OTCQB: XSHLF) a specialty finance company engaged in equipment leasing in the United States, is pleased to provide an update on original equipment manufacturers (“OEM”), within its Preferred Vendor Program. Jeremy Diehl, CTO of Green Mill Supercritical, commented, “In today’s leaner, smarter…
MONCTON, New Brunswick–(BUSINESS WIRE)–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce the launch of its most recent cannabis 2.0 product Trailblazer Snax, a premium-quality, value-priced, cannabis-infused chocolate bar. Made with premium quality ingredients including cocoa butter,…
DUBLIN–(BUSINESS WIRE)–The “Endocannabinoid System Targeted Therapeutics Market, 2020-2030” report has been added to ResearchAndMarkets.com’s offering. This report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of endocannabinoid system targeting drugs, over the next decade. The report features an in-depth analysis, highlighting the diverse capabilities of stakeholders…